CI Investments Inc
ITCI

CI Investments Inc’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

CI Investments Inc’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,722
Closed -$227K – 1355
2025
Q1 		$227K Sell
1,722
-818
-32% -$102K ﹤0.01% 693
2024
Q4 		$212K Buy
2,540
+230
+10% +$18.9K ﹤0.01% 720
2024
Q3 		$169K Buy
2,310
+30
+1% +$2.25K ﹤0.01% 708
2024
Q2 		$156K Sell
2,280
-197
-8% -$13.7K ﹤0.01% 700
2024
Q1 		$171K Buy
2,477
+1,033
+72% +$71K ﹤0.01% 744
2023
Q4 		$103K Sell
1,444
-248
-15% -$14.3K ﹤0.01% 826
2023
Q3 		$88K Buy
1,692
+1,561
+1,192% +$90.9K ﹤0.01% 850
2023
Q2 		$8K Buy
131
+126
+2,520% +$7.85K ﹤0.01% 1207
2023
Q1 		$0 Hold
5
– – ﹤0.01% 1335
2022
Q4 		$0 Hold
5
– – ﹤0.01% 1399
2022
Q3 		$0 Hold
5
– – ﹤0.01% 1391
2022
Q2 		$0 Buy
+5
New +$283 ﹤0.01% 1440

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CI Investments Inc's ITCI Position: Q2 2025 in Review

CI Investments Inc sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 1,722 shares — an estimated $227K sold.

CI Investments Inc first reported a position in ITCI in Q2 2022 and held it in 12 quarters. The position peaked at $227K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • CI Investments Inc reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • CI Investments Inc sold 1,722 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $227K.
  • CI Investments Inc first reported a position in Intra-Cellular Therapies Inc. in Q2 2022 and held it in 12 quarters.
  • CI Investments Inc's Intra-Cellular Therapies Inc. position peaked at $227K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on CI Investments Inc's 13F filing for Q2 2025, filed 12 Aug 2025.